BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 35639959)

  • 21. Angioimmunoblastic T-cell lymphoma contains multiple clonal T-cell populations derived from a common TET2 mutant progenitor cell.
    Yao WQ; Wu F; Zhang W; Chuang SS; Thompson JS; Chen Z; Zhang SW; Clipson A; Wang M; Liu H; Bibawi H; Huang Y; Campos L; Grant JW; Wright P; Ei-Daly H; Rásó-Barnett L; Farkas L; Follows GA; Gao Z; Attygalle AD; Ashton-Key M; Liu W; Du MQ
    J Pathol; 2020 Mar; 250(3):346-357. PubMed ID: 31859368
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Frequency, distribution, and immunomorphologic characteristics of peripheral T-cell lymphoma, not otherwise specified in a tertiary care center in Southern India.
    Lakshmanan A; Sikri D; Patil S; Kurian A; Annapurneswari S; Nair S
    Indian J Pathol Microbiol; 2018; 61(2):204-208. PubMed ID: 29676358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epigenetic alterations and advancement of treatment in peripheral T-cell lymphoma.
    Zhang P; Zhang M
    Clin Epigenetics; 2020 Nov; 12(1):169. PubMed ID: 33160401
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutation analysis links angioimmunoblastic T-cell lymphoma to clonal hematopoiesis and smoking.
    Cheng S; Zhang W; Inghirami G; Tam W
    Elife; 2021 Sep; 10():. PubMed ID: 34581268
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-Throughput Sequence Analysis of Peripheral T-Cell Lymphomas Indicates Subtype-Specific Viral Gene Expression Patterns and Immune Cell Microenvironments.
    Nakhoul H; Lin Z; Wang X; Roberts C; Dong Y; Flemington E
    mSphere; 2019 Jul; 4(4):. PubMed ID: 31292228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary cutaneous peripheral T-cell lymphomas with a T-follicular helper phenotype: an integrative clinical, pathological and molecular case series study.
    Wang L; Rocas D; Dalle S; Sako N; Pelletier L; Martin N; Dupuy A; Tazi N; Balme B; Vergier B; Beylot-Barry M; Carlotti A; Bagot M; Battistella M; Chaby G; Ingen-Housz-Oro S; Gaulard P; Ortonne N
    Br J Dermatol; 2022 Dec; 187(6):970-980. PubMed ID: 35895386
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of telomerase reverse transcriptase in peripheral T-cell lymphoma.
    Arakawa F; Miyoshi H; Yoshida N; Nakashima K; Watatani Y; Furuta T; Yamada K; Moritsubo M; Takeuchi M; Yanagida E; Shimasaki Y; Kohno K; Kataoka K; Ohshima K
    Cancer Med; 2021 Oct; 10(19):6786-6794. PubMed ID: 34477310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular understanding of peripheral T-cell lymphomas, not otherwise specified (PTCL, NOS): A complex disease category.
    Sakata-Yanagimoto M; Fukumoto K; Karube K; Chiba S
    J Clin Exp Hematop; 2021 Jun; 61(2):61-70. PubMed ID: 33716242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic markers in peripheral T-cell lymphoma.
    Piccaluga PP; Agostinelli C; Gazzola A; Mannu C; Bacci F; Sabattini E; Pileri SA
    Curr Hematol Malig Rep; 2010 Oct; 5(4):222-8. PubMed ID: 20690003
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum IgA level, monocyte count, and international prognostic index are independently associated with overall survival in patients with HTLV-I-negative nodal peripheral T cell lymphoma.
    Kato A; Imai Y; Aoki K; Tabata S; Matsushita A; Hashimoto H; Takahashi T; Ishikawa T
    Ann Hematol; 2014 Jul; 93(7):1185-91. PubMed ID: 24526138
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overlap at the molecular and immunohistochemical levels between angioimmunoblastic T-cell lymphoma and a subgroup of peripheral T-cell lymphomas without specific morphological features.
    Manso R; González-Rincón J; Rodríguez-Justo M; Roncador G; Gómez S; Sánchez-Beato M; Piris MA; Rodríguez-Pinilla SM
    Oncotarget; 2018 Mar; 9(22):16124-16133. PubMed ID: 29662631
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epstein-Barr virus-positive nodal peripheral T cell lymphomas: clinicopathologic and gene expression profiling study.
    Ha SY; Sung J; Ju H; Karube K; Kim SJ; Kim WS; Seto M; Ko YH
    Pathol Res Pract; 2013 Jul; 209(7):448-54. PubMed ID: 23735590
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peripheral T-cell lymphomas in a large US multicenter cohort: prognostication in the modern era including impact of frontline therapy.
    Abramson JS; Feldman T; Kroll-Desrosiers AR; Muffly LS; Winer E; Flowers CR; Lansigan F; Nabhan C; Nastoupil LJ; Nath R; Goy A; Castillo JJ; Jagadeesh D; Woda B; Rosen ST; Smith SM; Evens AM
    Ann Oncol; 2014 Nov; 25(11):2211-2217. PubMed ID: 25193992
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas.
    Palomero T; Couronné L; Khiabanian H; Kim MY; Ambesi-Impiombato A; Perez-Garcia A; Carpenter Z; Abate F; Allegretta M; Haydu JE; Jiang X; Lossos IS; Nicolas C; Balbin M; Bastard C; Bhagat G; Piris MA; Campo E; Bernard OA; Rabadan R; Ferrando AA
    Nat Genet; 2014 Feb; 46(2):166-70. PubMed ID: 24413734
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dnmt3a Is a Haploinsufficient Tumor Suppressor in CD8+ Peripheral T Cell Lymphoma.
    Haney SL; Upchurch GM; Opavska J; Klinkebiel D; Hlady RA; Roy S; Dutta S; Datta K; Opavsky R
    PLoS Genet; 2016 Sep; 12(9):e1006334. PubMed ID: 27690235
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinicopathologic and Genetic Features of Primary T-cell Lymphomas of the Central Nervous System: An Analysis of 11 Cases Using Targeted Gene Sequencing.
    Yim J; Koh J; Kim S; Song SG; Bae JM; Yun H; Sung JY; Kim TM; Park SH; Jeon YK
    Am J Surg Pathol; 2022 Apr; 46(4):486-497. PubMed ID: 34980830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinicopathological Study of 30 Cases of Peripheral T-cell Lymphoma with Hodgkin and Reed-Sternberg-like B-cells from Japan.
    Eladl AE; Satou A; Elsayed AA; Suzuki Y; Kato S; Asano N; Nakamura S
    Am J Surg Pathol; 2017 Apr; 41(4):506-516. PubMed ID: 28125450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Classification and diagnostic evaluation of nodal T- and NK-cell lymphomas.
    Feldman AL; Laurent C; Narbaitz M; Nakamura S; Chan WC; de Leval L; Gaulard P
    Virchows Arch; 2023 Jan; 482(1):265-279. PubMed ID: 36210383
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene Expression Signatures for the Accurate Diagnosis of Peripheral T-Cell Lymphoma Entities in the Routine Clinical Practice.
    Amador C; Bouska A; Wright G; Weisenburger DD; Feldman AL; Greiner TC; Lone W; Heavican T; Smith L; Pileri S; Tabanelli V; Ott G; Rosenwald A; Savage KJ; Slack G; Kim WS; Hyeh Y; Li Y; Dong G; Song J; Ondrejka S; Cook JR; Barrionuevo C; Lim ST; Ong CK; Chapman J; Inghirami G; Raess PW; Bhagavathi S; Gould C; Blombery P; Jaffe E; Morris SW; Rimsza LM; Vose JM; Staudt L; Chan WC; Iqbal J
    J Clin Oncol; 2022 Dec; 40(36):4261-4275. PubMed ID: 35839444
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunophenotypic classification regarding prognosis in peripheral T cell lymphoma, NOS, and nodal T follicular helper T cell lymphoma, angioimmunoblastic-type.
    Choi S; Jo JC; Lee YJ; Chae SW; Cha HJ
    Ann Hematol; 2024 May; ():. PubMed ID: 38814447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.